Learn more about how Mayo Clinic Laboratories’ genetic gastroenterology tests can provide diagnostic clarity across a range of inherited GI disorders.
A worldwide increase of the incidence of early-onset pediatric inflammatory bowel disease means more children than ever are diagnosed and treated for life-altering IBD diagnoses. However, not all children suspected of early-onset IBD have...
Malabsorption panel - Insights
Mayo Clinic Laboratories, which is integrated with the clinical gastroenterology practice at Mayo Clinic, understands the worry patients and their loved ones feel while awaiting test results. To expedite and streamline the diagnostic...
Comprehensive panels - Insights
Check out Mayo Clinic Laboratories’ comprehensive pharmacogenomic panels, which identify genetic variations associated with treatment response.
Purine and pyrimidine metabolism disorders - Insights
Check out how Mayo Clinic Laboratories’ genetic testing can help to diagnose and monitor patients affected by purine and pyrimidine metabolism disorders.
Advanced Phlebotomy Collections - Insights
Find out about advanced blood collection techniques and the specialized procedures that are used when standard blood collection methods may not be feasible or when specific tests require more specialized handling of blood samples.
Safety in Phlebotomy - Insights
Get a general introduction to safety precautions, which will help ensure the well-being of you and your patients.
Specimen Integrity and Processing - Insights
Learn about the variables influencing successful blood draws and their potential impact on laboratory outcomes, Quality Assurance principles, the regulatory agencies ensuring patient and healthcare worker safety, and the organizational...
Difficult Collections and Special Populations - Insights
Get an overview of phlebotomy techniques for pediatric and geriatric patients who often present as unique challenges due to their physiological and anatomical differences.
Neuromuscular panel - Insights
Find out how the emergence of advanced molecular testing technologies has enhanced the detection of inherited neuromuscular disorders.